On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...